Arca
Skip to content
Tools
Tools

Cellulitis

Drug research and approvals for cellulitis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 18, 2026, 12 studies of cellulitis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 2 drug trials for it since 2013.

  • Recruiting worldwide: 12
  • Trials authorized in Canada: 2
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest start dates first, of 12 recruiting on ClinicalTrials.gov ↗

Drug pipeline

2 approved, 7 in phase 3, 3 in phase 2; from ChEMBL's drug indications, furthest stage reached for this condition

Approved: Tazobactam, Piperacillin

Vancomycin
Phase 3 Peptidoglycan inhibitor
Cefazolin
Phase 3 Bacterial penicillin-binding protein inhibitor
Moxifloxacin
Phase 3 Topoisomerase IV inhibitor
Linezolid
Phase 3 Bacterial 70S ribosome inhibitor
Oritavancin
Phase 3 Peptidoglycan inhibitor
Dalbavancin
Phase 3 Peptidoglycan inhibitor
Floxacillin
Phase 3 Bacterial penicillin-binding protein inhibitor
Probenecid
Phase 2 Solute carrier family 22 member 6 inhibitor
Cephalexin anhydrous
Phase 2 Bacterial penicillin-binding protein inhibitor
Levofloxacin anhydrous
Phase 2 DNA gyrase inhibitor

How its trials ended

151 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 46 whose ending is known, 61% met their primary endpoint, 13% missed it and 26% stopped early.

  • Completed, result not reported7046%
  • Met its primary endpoint2819%
  • Ongoing2013%
  • Status unknown1510%
  • Missed its primary endpoint64%
  • Stopped: other or unclear53%
  • Stopped: enrollment or feasibility43%
  • Stopped: funding21%
  • Stopped: lack of efficacy11%

Trials authorized in Canada

Newest first; search them all in Canada trials
Jul 14, 2026Naproxen versus placebo as adjunct treatment of cellulitis: a randomized controlled trialNaproxenOttawa Hospital Research InstitutePending
Jan 15, 2026Dexamethasone vs. placebo in children and youth hospitalized for orbital cellulitis: the vision pilot randomized clinical trialDexamethasoneThe Hospital for Sick ChildrenPending

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.